Wen Feng Zeng

Title: The Innovative Contributions of Wen Feng Zeng

Introduction

Wen Feng Zeng is a notable inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the area of tumor radiotherapy. His work focuses on the application of small molecular flavonoid compounds in enhancing the effectiveness of radiation therapy for tumors.

Latest Patents

Wen Feng Zeng holds a patent titled "Application of naringenin and naringin in tumor radiotherapy." This invention provides applications of a small molecular flavonoid compound in preparing a medication that sensitizes and synergizes tumor radiation therapy while reducing radioactive damage. The small molecular flavonoid compounds mentioned in the patent include naringenin, hesperetin, luteolin, and apigenin. The medication comprises a small molecular flavonoid compound as the active ingredient along with various conventional pharmaceutical additives.

Career Highlights

Throughout his career, Wen Feng Zeng has worked with prestigious organizations such as the Chinese Academy of Sciences and Topfond Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to contribute to significant advancements in medical research and innovation.

Collaborations

Wen Feng Zeng has collaborated with notable colleagues, including Wei Liang and Chun Ling Zhang. These partnerships have further enriched his research and development efforts in the field of tumor treatment.

Conclusion

Wen Feng Zeng's innovative work in the application of flavonoid compounds for tumor radiotherapy showcases his dedication to advancing medical science. His contributions are vital in the ongoing quest to improve cancer treatment methodologies.